Where does Valencia Bioscience, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Valencia Bioscience, Inc. ranks #25,483 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Valencia Bioscience, Inc. hold?

Valencia Bioscience, Inc. holds 11 US utility patents granted between 2021 and 2025, spanning 6 technology areas.

What is Valencia Bioscience, Inc.'s Innovation Score?

Valencia Bioscience, Inc. has an Innovation Score of 43.9 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Valencia Bioscience, Inc. focus on?

Valencia Bioscience, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 11 patents, ranking #336 of 1,943 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Valencia Bioscience, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Valencia Bioscience, Inc..

What does claim depth mean for Valencia Bioscience, Inc.'s patents?

Valencia Bioscience, Inc.'s patents average 18.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Valencia Bioscience, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Valencia Bioscience, Inc.

USPTO PatentsView assignee record - 11 granted patents across 6 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Valencia ranks #25,483 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 6 technology areas.

#25,483
of 49,997 US assignees by volume: Top 27%
by Innovation Score (43.9/100): 18.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R25483 · US Corporation #25,483 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 11 grants
MID-PACK #25,483/49,997
PHOTO-FINISH Vacuum
CPC-NARROW A61N · 6 areas
INNOV-PAR 43.9/100
CLAIMS-RICH 18.4 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Vacuum Technologies, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Valencia’s 43.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (20%) Velocity 15.6 pts (35%) Breadth 8.7 pts (20%) Claim depth 11.1 pts (25%)

Qualcomm Incorporated · highest

85
Valencia Bioscience · this assignee

44
3D Lighting… · lowest

7

What this shows Valencia's Innovation Score is 43.9/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Valencia?

Each dot is one of Valencia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Valencia’s own 18.4 claims/patent is ABOVE the 15.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Valencia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Valencia's grants concentrate

Valencia Bioscience, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2024. By volume, Valencia sits between VON ARX AG and Vascular Access Technologies, Inc..

Valencia's three-year grant acceleration

Valencia Bioscience, Inc. shows 7 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

VON ARX

11
Vpay

11
Vygon

11
Vacuum

11
Valeo Lighting Hu…

11
Valerion Therapeu…

11
Vanguard Group

11
Vascular Access

11
Valencia Bioscien… ◀

11

What this shows Valencia holds 11 patents at rank #25,488, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Valencia

By rank, the assignees closest to #25,488 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Valencia's primary technology class.

Valencia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Valencia Bioscience, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	3	27.3%
2022	3	27.3%
2023	3	27.3%
2024	1	9.1%
2025partial year	1	9.1%

Which technologies does Valencia Bioscience, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 11

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 10

Y10T - Technical Subjects Covered BY Former US Classification 7

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 3

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 2

H01L - Semiconductor Devices NOT Covered BY Class H10 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Valencia Bioscience, Inc.'s patent record in context - here's where to go next.

Valencia Bioscience, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #25,483 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Valencia Bioscience, Inc. against VON ARX AG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.